Leiomyosarcoma

Leiomyosarcoma is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Leiomyosarcomas · Leiomyosarcoma (LMS) · LMS - Leiomyosarcoma
Classified under: Musculoskeletal and Connective Tissue Diseases
Neoplasms
Indicated drugs: Sorafenib

Resolves to

Vocabularies

MeSHM0012318SNOMED CT1163022006MedDRA10024190UMLSC0023269

What you can answer from here — as of October 11, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

150Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Leiomyosarcoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.